Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/11986
Title: | Possibilities of aldosterone antagonist use in the correction of left ventricular diastolic dysfunction in patients with chronic obstructive pulmonary disease |
Authors: | Кравчун, Павло Григорович Дєлєвська, Валентина Юріївна Риндіна, Наталія Геннадіївна Kravchun, Pavlo H. Dielievska, Valentyna Ryndina, Natalia |
Keywords: | arterial hypertension chronic obstructive pulmonary disease diastolic function spironolactone |
Issue Date: | 21-May-2015 |
Citation: | Kravchun P. G. Possibilities of aldosterone antagonist use in the correction of left ventricular diastolic dysfunction in patients with chronic obstructive pulmonary disease / P. G. Kravchun, V. Yu. Dielievska, N. G. Ryndina // Кардиология в Беларуси. – 2015. – Прилож. : Артериальная гипертензия и профилактика сердечно-сосудистых заболеваний : материалы VIII международной конференции, Витебск (Беларусь), 21–22 мая 2015. – С. 9–11. |
Abstract: | The objective: to study the effictiveness of spironolactone in diastolic function improvement of left ventricle (LV) in patients with arterial hypertension (AH)in combination with chronic obstructive pulmonary disease (COPD). Conclusions. Thus, different results of LV diastolic function dynamics in patients with AH and COPD having received basic therapy with or without spironolactone, suggests that spironolactone has a cardioprotective effect in patients with AH and COPD. The results demonstrate the effectiveness of spironolactone in improving diastolic dysfunction of LN in patients with AH and COPD. |
URI: | https://repo.knmu.edu.ua/handle/123456789/11986 |
Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 2 і клінічної імунології та алергології ім. ак. Л.Т. Малої |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Делевська Possibilities of aldosterone antagonist use in the correction.doc | 56 kB | Microsoft Word | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.